Hemogenyx secures clearance for pediatric enrolment in leukemia trial
(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukemia treatment. Read More
| Price | 856.00p on 12-11-2025 at 19:20:06 |
|---|---|
| Change | -14.00p -1.61% |
| Buy | 900.00p |
| Sell | 874.00p |
| Last Trade: | Unknown 1,500.00 at 902.00p |
| Day's Volume: | 11,929 |
| Last Close: | 856.00p |
| Open: | 960.00p |
| ISIN: | GB00BQVXM815 |
| Day's Range | 856.00p - 960.00p |
| 52wk Range: | 0.876p - 1,790.00p |
| Market Capitalisation: | £45.89m |
| VWAP: | 892.40511p |
| Shares in Issue: | 5.36m |
Sector: Medicine and Biotech
Hemogenyx Pharmaceuticals (HEMO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 1,500 | 902.00p | Negotiated Trade |
16:37:35 - 12-Nov-25 |
| Buy* | 1,332 | 856.00p | Suspected BUY Trade |
16:35:12 - 12-Nov-25 |
| Unknown* | 2,248 | 915.00p | Negotiated Trade |
16:29:57 - 12-Nov-25 |
| Buy* | 100 | 889.5908p | Ordinary |
16:16:52 - 12-Nov-25 |
| Sell* | 59 | 870.36p | Ordinary |
16:16:49 - 12-Nov-25 |
| Sell* | 162 | 862.00p | SI Trade |
16:14:09 - 12-Nov-25 |
| Buy* | 17 | 900.00p | SI Trade |
16:12:54 - 12-Nov-25 |
| Sell* | 2 | 862.00p | SI Trade |
16:12:54 - 12-Nov-25 |
| Sell* | 43 | 862.00p | SI Trade |
16:12:54 - 12-Nov-25 |
| Sell* | 3 | 862.00p | SI Trade |
16:12:54 - 12-Nov-25 |
Hemogenyx Pharmaceuticals (HEMO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 29th Oct 2025 7:00 am | RNS | Clinical Trial Update and Grant of Share Awards |
| 6th Oct 2025 7:00 am | RNS | Clearance to Initiate Pediatric Enrolment |
| 30th Sep 2025 7:00 am | RNS | Half-year Report |
| 30th Sep 2025 7:00 am | RNS | Total Voting Rights |
| 23rd Sep 2025 7:00 am | RNS | Hemogenyx Signs Letter of Intent |
| 18th Sep 2025 1:16 pm | RNS | Holding(s) in Company |
| 17th Sep 2025 7:00 am | RNS | Third Patient Safety |
| 11th Sep 2025 7:00 am | RNS-R | Invitation to Participate at DCNY Summit |
| 8th Sep 2025 7:00 am | RNS | Manufacturing Partnership with Made Scientific |
| 5th Sep 2025 7:00 am | RNS | Exercise of Warrants and Issue of Equity |